These changes in expression levels were confirmed on protein level by western blot analysis (Fig. 12B,D), indicating that ezrin, galectin‐3, and FGFb are target genes in L1CAM signaling in RB cells. The gene discussed is FGF2; the disease is retinoblastoma.